Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in advanced breast cancer
NCT00089973Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ispinesib in breast cancer, sponsored by GSK. Started Jun 2004; status: completed.
02
Drugs
ispinesib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00089973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089973.